Ian G. McKeith

Ian G. McKeith's AcademicInfluence.com Rankings

Ian G. McKeith

Philosophy

#4856

World Rank

#7517

Historical Rank

Logic

#2266

World Rank

#3224

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Ian G. McKeith Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Ian G. McKeith is a professor of Old Age Psychiatry at Newcastle University in Newcastle upon Tyne in the North-East of England. He is a Fellow of the Royal Society of Biology and a Fellow of the Academy of Medical Sciences.

(See a Problem?)

Ian G. McKeith's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Diagnosis and management of dementia with Lewy bodies (2005) (3346)
Clinical diagnostic criteria for dementia associated with Parkinson's disease (2007) (2413)
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. (1996) (2280)
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) (1996) (2138)
Diagnosis and management of dementia with Lewy bodies (2017) (1606)
Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales (2001) (1205)
Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study (2000) (1066)
SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders (2003) (971)
Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force (2007) (918)
Neuroleptic sensitivity in patients with senile dementia of Lewy body type. (1992) (641)
Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. (2004) (606)
Donepezil and memantine for moderate-to-severe Alzheimer's disease. (2012) (575)
Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study (2007) (543)
Prospective validation of Consensus criteria for the diagnosis of dementia with Lewy bodies (2000) (451)
A comprehensive study of gray matter loss in patients with Alzheimer’s disease using optimized voxel-based morphometry (2003) (432)
Operational criteria for senile dementia of Lewy body type (SDLT) (1992) (429)
White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging (1999) (412)
Multifactorial intervention after a fall in older people with cognitive impairment and dementia presenting to the accident and emergency department: randomised controlled trial (2003) (400)
Why people see things that are not there: A novel Perception and Attention Deficit model for recurrent complex visual hallucinations (2005) (380)
A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. (2004) (378)
Motor subtype and cognitive decline in Parkinson’s disease, Parkinson’s disease with dementia, and dementia with Lewy bodies (2006) (374)
Education, the brain and dementia: neuroprotection or compensation? (2010) (361)
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. (2013) (357)
The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia. (2000) (354)
DLB and PDD boundary issues (2007) (351)
Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. (2004) (330)
Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population (2009) (329)
A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II (2016) (329)
Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. (1999) (326)
Health related quality of life in Parkinson's disease: a prospective longitudinal study (2000) (321)
Differences in neuropathologic characteristics across the Lewy body dementia spectrum (2006) (308)
Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease. (1999) (304)
A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia (2001) (302)
Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy (2007) (282)
Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand (2002) (280)
Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease (2006) (275)
Visual perception in Parkinson disease dementia and dementia with Lewy bodies (2004) (274)
5HT2 receptor changes in major depression (1990) (265)
Frontotemporal dementia and its subtypes: a genome-wide association study (2014) (262)
Epidemiological Pathology of Dementia: Attributable-Risks at Death in the Medical Research Council Cognitive Function and Ageing Study (2009) (262)
Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: Preliminary findings from an open trial (2001) (259)
Neuronal Nicotinic Receptors in Dementia with Lewy Bodies and Schizophrenia (1999) (257)
Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. (1994) (256)
The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts (2007) (234)
Research criteria for the diagnosis of prodromal dementia with Lewy bodies (2020) (232)
Effects of Rivastigmine on Cognitive Function in Dementia with Lewy Bodies: A Randomised Placebo-Controlled International Study Using the Cognitive Drug Research Computerised Assessment System (2002) (223)
Anxiety, depression and psychosis in vascular dementia: prevalence and associations. (2000) (218)
Cholinergic Transmitter and Neurotrophic Activities in Lewy Body Dementia: Similarity to Parkinson's and Distinction from Alzheimer Disease (1993) (212)
Dementia with Lewy bodies. (2007) (212)
Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia (2001) (211)
Systematic Review and Meta-Analysis Show that Dementia with Lewy Bodies Is a Visual-Perceptual and Attentional-Executive Dementia (2003) (211)
Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology (2011) (210)
Patterns of Cerebral Atrophy in Dementia with Lewy Bodies Using Voxel-Based Morphometry (2002) (207)
Autonomic dysfunction in dementia (2006) (206)
Two‐Year Progression from Mild Cognitive Impairment to Dementia: To What Extent Do Different Definitions Agree? (2008) (206)
Temporal lobe atrophy on MRI in Parkinson disease with dementia (2005) (205)
Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases. (2000) (204)
Behavioural changes and psychological symptoms in dementia disorders (2005) (204)
Cognitive Performance in Hypertensive and Normotensive Older Subjects (2000) (199)
Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. (2005) (197)
Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies. (2005) (194)
A comparison of 99mTc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping (2002) (183)
Patterns and stages of &agr;-synucleinopathy: Relevance in a population-based cohort (2008) (183)
Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis. (2015) (180)
Attention and fluctuating attention in patients with dementia with Lewy bodies and Alzheimer disease. (2001) (176)
The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis (2014) (176)
An evaluation of the predictive validity and inter‐rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type (1994) (174)
The natural history of psychosis and depression in dementia with Lewy bodies and Alzheimer's disease: persistence and new cases over 1 year of follow-up. (2001) (170)
Causes of death in a community‐based study of Parkinson's disease (2001) (166)
How to diagnose dementia with Lewy bodies: State of the art (2005) (166)
Role of Cholinesterase Inhibitors in Parkinson’s Disease and dementia with Lewy Bodies (2004) (164)
Fluctuations in attention (2002) (160)
Delusions associated with elevated muscarinic binding in dementia with Lewy bodies (2000) (160)
Dementia with Lewy bodies (2004) (158)
Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial (2000) (157)
Topography, Extent, and Clinical Relevance of Neurochemical Deficits in Dementia of Lewy Body Type, Parkinson's Disease, and Alzheimer's Disease (1991) (157)
Benefits of rivastigmine on attention in dementia associated with Parkinson disease (2005) (156)
Characteristics of visual hallucinations in Parkinson disease dementia and dementia with lewy bodies. (2006) (155)
The role of levodopa in the management of dementia with Lewy bodies (2005) (153)
Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross‐sectional comparative study (2003) (153)
Parietal white matter lesions in Alzheimer’s disease are associated with cortical neurodegenerative pathology, but not with small vessel disease (2017) (152)
Dementia with Lewy bodies: an update and outlook (2019) (152)
EEG findings in dementia with Lewy bodies and Alzheimer’s disease (1999) (151)
A comparison of sleep profiles in patients with dementia with Lewy bodies and Alzheimer's disease (2000) (151)
Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia. (2000) (150)
Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease (2004) (144)
Regional cerebral blood flow in Parkinson's disease with and without dementia (2003) (144)
TDP‐43 pathology in Alzheimer's disease, dementia with Lewy bodies and ageing (2017) (144)
Determining the minimum clinically important differences for outcomes in the DOMINO trial (2011) (132)
Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies. (2004) (132)
Long-Term Use of Rivastigmine in Patients With Dementia With Lewy Bodies: An Open-Label Trial (2001) (130)
Neuroleptic sensitivity to risperidone in Lewy body dementia (1995) (130)
5-HT receptor binding in post-mortem brain from patients with affective disorder. (1987) (130)
Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review (2013) (128)
Foresight Mental Capital and Wellbeing Project (2014) (126)
What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia (2003) (124)
Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies (2009) (124)
Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation (2006) (123)
Effect of levodopa on cognitive function in Parkinson’s disease with and without dementia and dementia with Lewy bodies (2006) (123)
The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease (2001) (123)
Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses (2015) (122)
Dementia with Lewy bodies: diagnosis and management (2001) (120)
Olanzapine in dementia with Lewy bodies: a clinical study (1999) (119)
Dementia with Lewy bodies (2002) (119)
Clinical prevalence of Lewy body dementia (2018) (117)
New evidence on the management of Lewy body dementia (2020) (116)
The Prevalence, Assessment and Associations of Falls in Dementia with Lewy Bodies and Alzheimer’s Disease (1999) (114)
Early Cognitive Change in the General Population: How Do Different Definitions Work? (2007) (114)
Progression of white matter hyperintensities in Alzheimer disease, dementia with lewy bodies, and Parkinson disease dementia: a comparison with normal aging. (2006) (112)
The Clinical Diagnosis and Misdiagnosis of Senile Dementia of Lewy Body Type (SDLT) (1994) (111)
Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging (2005) (109)
Subjectively reported sleep quality and excessive daytime somnolence in Parkinson's disease with and without dementia, dementia with Lewy bodies and Alzheimer's disease (2007) (107)
MRI Study of Caudate Nucleus Volume in Parkinson’s Disease with and without Dementia with Lewy Bodies and Alzheimer’s Disease (2003) (104)
Candesartan and cognitive decline in older patients with hypertension (2008) (104)
Effects of hypertension on attention, memory, and executive function in older adults. (2003) (104)
A Comparison of Medial and Lateral Temporal Lobe Atrophy in Dementia with Lewy Bodies and Alzheimer’s Disease: Magnetic Resonance Imaging Volumetric Study (2001) (103)
Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer’s disease (2003) (103)
Apolipoprotein E genes in Lewy body and Parkinson's disease (1994) (102)
Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB (2017) (102)
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture (2021) (99)
Dementia with Lewy bodies: findings from an international multicentre study (2000) (98)
Volumetric MRI study of the caudate nucleus in patients with dementia with Lewy bodies, Alzheimer's disease, and vascular dementia (2002) (98)
A semi‐structured interview to assess visual hallucinations in older people (2008) (98)
Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases (1991) (95)
Studies on the serotonin uptake binding site in major depressive disorder and control post-mortem brain: Neurochemical and clinical correlates (1991) (95)
Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease using cortical pattern matching: diagnosis and gender effects (2004) (95)
What electrophysiology tells us about Alzheimer's disease: a window into the synchronization and connectivity of brain neurons (2019) (94)
Dementia with Lewy bodies and Parkinson's disease. (2004) (94)
Examining carer stress in dementia: the role of subtype diagnosis and neuropsychiatric symptoms (2013) (94)
Dementia with Lewy bodies and Parkinson’s disease with dementia: where two worlds collide (2007) (92)
Depression with late onset is associated with right frontal lobe atrophy (2003) (91)
A comparison of the efficacy of donepezil in Parkinson's disease with Dementia and Dementia with Lewy bodies (2005) (90)
Neuropathological Substrates of Dementia and Depression in Vascular Dementia, with a Particular Focus on Cases with Small Infarct Volumes (2000) (86)
Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson’s disease with and without dementia assessed using 123I-FP-CIT SPECT (2005) (85)
Regulation of attention and response to therapy in dementia by butyrylcholinesterase. (2003) (85)
Quantification and Characterisation of Fluctuating Cognition in Dementia with Lewy Bodies and Alzheimer’s Disease (2000) (84)
Association among visual hallucinations, visual acuity, and specific eye pathologies in Alzheimer's disease: treatment implications. (1999) (83)
Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions (2003) (82)
Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease (2003) (81)
Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia. (2018) (81)
Cortical Thickness in Dementia with Lewy Bodies and Alzheimer's Disease: A Comparison of Prodromal and Dementia Stages (2015) (80)
Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein. (1994) (80)
High prevalence of neurovascular instability in neurodegenerative dementias (1998) (80)
APOA1 polymorphism influences risk for early‐onset nonfamiliar AD (2005) (79)
Clinical neurochemistry: developments in dementia research based on brain bank material (1998) (78)
A Comparison of Computerized and Pencil‐and‐Paper Tasks in Assessing Cognitive Function in Community‐Dwelling Older People in the Newcastle 85+ Pilot Study (2007) (77)
Visual complaints and visual hallucinations in Parkinson's disease. (2014) (76)
Visual cortex in dementia with Lewy bodies: magnetic resonance imaging study (2012) (76)
Poor attentional function predicts cognitive decline in patients with non-demented Parkinson’s disease independent of motor phenotype (2008) (76)
Apolipoprotein E ϵ4 Allele, Temporal Lobe Atrophy, and White Matter Lesions in Late-Life Dementias (1999) (75)
Pathological correlates of frontotemporal lobar degeneration in the elderly (2011) (73)
Neurocardiovascular Instability, Hypotensive Episodes, and MRI Lesions in Neurodegenerative Dementia (2000) (72)
Gastrointestinal absorption of aluminium in Alzheimer's disease: response to aluminium citrate. (1992) (71)
Pathophysiology of synuclein aggregation in Lewy body disease (2006) (71)
Hallucinations Predict Attentional Improvements with Rivastigmine in Dementia with Lewy Bodies (2004) (71)
Change in perfusion, hallucinations and fluctuations in consciousness in dementia with Lewy bodies (2005) (70)
α4β2 nicotinic receptor status in Alzheimer’s disease using 123I-5IA-85380 single-photon-emission computed tomography (2006) (70)
A Detailed Phenomenological Comparison of Complex Visual Hallucinations in Dementia With Lewy Bodies and Alzheimer's Disease (1997) (68)
More severe functional impairment in dementia with lewy bodies than Alzheimer disease is related to extrapyramidal motor dysfunction. (2006) (67)
The Prevalence of Autonomic Symptoms in Dementia and Their Association with Physical Activity, Activities of Daily Living and Quality of Life (2006) (67)
A comparative study of attentional deficits in senile dementias of Alzheimer and lewy body types (1992) (67)
Matching-to-sample deficits in patients with senile dementias of the Alzheimer and Lewy body types. (1992) (67)
Revisiting DLB Diagnosis (2016) (66)
Nigrostriatal dopaminergic activities in dementia with lewy bodies in relation to neuroleptic sensitivity: comparisons with parkinson’s disease (1998) (65)
Grey matter atrophy in prodromal stage of dementia with Lewy bodies and Alzheimer’s disease (2016) (65)
Accumulation of dipeptide repeat proteins predates that of TDP‐43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene (2015) (65)
Cholinesterase inhibitors reduce cortical Aβ in dementia with Lewy bodies (2007) (65)
Mortality and Parkinson disease (2004) (64)
Clinical and Neuropathological Correlates of Apolipoprotein E Genotype in Dementia with Lewy Bodies (2002) (64)
Monoaminergic activities in Lewy Body dementia: Relation to hallucinosis and extrapyramidal features (1993) (62)
Clinical use of the DST in a Psychogeriatric Population (1984) (62)
Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort. (2017) (62)
Diagnosing dementia with Lewy bodies (1999) (62)
Detection of visual memory and learning deficits in Alzheimer's disease using the Cambridge neuropsychological test automated battery (1991) (61)
Butyrylcholinesterase and progression of cognitive deficits in dementia with Lewy bodies (2003) (61)
Neuropsychiatric symptoms and cognitive profile in mild cognitive impairment with Lewy bodies (2018) (61)
Single‐cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene (2009) (60)
The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease (2004) (60)
Visual hallucinations in dementia with Lewy bodies: transcranial magnetic stimulation study (2011) (60)
A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies (2008) (60)
The characterisation and impact of ‘fluctuating’ cognition in dementia with Lewy bodies and Alzheimer's disease (2001) (59)
Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management (2020) (59)
Lewy Body Dementia – Diagnosis and Treatment (1995) (59)
Arguing against the proposed definition changes of PD (2016) (58)
The dementia cognitive fluctuation scale, a new psychometric test for clinicians to identify cognitive fluctuations in people with dementia. (2014) (57)
Operationalisation of Mild Cognitive Impairment: A Graphical Approach (2007) (57)
Simple Standardised NeuropsychologicalAssessments Aid in the Differential Diagnosis of Dementia with Lewy Bodies from Alzheimer’s Disease and Vascular Dementia (1999) (56)
Comparison of Extrapyramidal Signs in Dementia With Lewy Bodies and Parkinson's Disease (2001) (55)
Glucocerebrosidase Mutations alter the endoplasmic reticulum and lysosomes in Lewy body disease (2012) (55)
How do memory clinics compare with traditional old age psychiatry services? (2001) (55)
In vivo SPECT imaging of muscarinic acetylcholine receptors using (R,R) 123I-QNB in dementia with Lewy bodies and Parkinson’s disease dementia (2006) (54)
Mild cognitive impairment in the older population: Who is missed and does it matter? (2008) (53)
Muscarinic M2 and M4 receptors in anterior cingulate cortex: relation to neuropsychiatric symptoms in dementia with Lewy bodies (2005) (52)
Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study (2021) (52)
Effects of Donepezil on Central Processing Speed and Attentional Measures in Parkinson’s Disease with Dementia and Dementia with Lewy Bodies (2006) (51)
Diagnostic accuracy of dopaminergic imaging in prodromal dementia with Lewy bodies (2018) (51)
Nicotinic α4β2 receptor binding in dementia with Lewy bodies using 123I-5IA-85380 SPECT demonstrates a link between occipital changes and visual hallucinations (2008) (51)
Cost‐effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO‐AD trial) (2016) (50)
Frontotemporal dementia in elderly individuals. (2012) (50)
Effects of combined methohexitone‐remifentanil anaesthesia in electroconvulsive therapy (2001) (49)
DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease – a multicentre RCT (2009) (49)
Magnetic resonance imaging differences between dementia with Lewy bodies and Alzheimer's disease: a pilot study (1999) (48)
Synaptic Proteins and Choline Acetyltransferase Loss in Visual Cortex in Dementia With Lewy Bodies (2013) (47)
Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations (2016) (47)
Effects of apolipoprotein E genotype on cortical neuropathology in senile dementia of the Lewy body and Alzheimer's disease. (1995) (46)
Relationship between mitochondria and α-synuclein: a study of single substantia nigra neurons. (2012) (46)
Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson's disease. (2001) (46)
Cholinesterase inhibitors in dementia with Lewy bodies—a comparative analysis (2007) (45)
HLA‐DR antigens associated with major genetic risk for late‐onset Alzheimer's disease (1997) (45)
Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment (2018) (45)
One Year Follow-Up of Parkinsonism in Dementia with Lewy Bodies (2000) (44)
Clinicians' ability to diagnose dementia with Lewy bodies is not affected by β-amyloid load (2015) (43)
Single Photon Emission Computerised Tomography in Elderly Patients with Alzheimer's Disease and Multi-infarct Dementia (1993) (43)
Clinical predictors of response to acetyl cholinesterase inhibitors: experience from routine clinical use in Newcastle (2003) (43)
A multicentre, randomized, double‐blind, placebo‐controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild‐to‐moderate Alzheimer's disease: the MALT study (1999) (43)
Resting state in Parkinson's disease dementia and dementia with Lewy bodies: commonalities and differences (2015) (43)
Alpha- and Gamma-Synuclein Proteins Are Present in Cerebrospinal Fluid and Are Increased in Aged Subjects with Neurodegenerative and Vascular Changes (2008) (41)
Cognitive decline and dementia risk in older adults with psychotic symptoms: a prospective cohort study. (2012) (41)
Medial Temporal Lobe Width on CT Scanning in Alzheimer’s Disease: Comparison with Vascular Dementia, Depression and Dementia with Lewy Bodies (2000) (41)
Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis (2020) (40)
Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials (2014) (40)
Lewy body disease: Thalamic cholinergic activity related to dementia and parkinsonism (2006) (40)
Optimizing mild cognitive impairment for discriminating dementia risk in the general older population. (2010) (39)
Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group. (1997) (39)
Nitric oxide synthase gene polymorphisms in Alzheimer's disease and dementia with Lewy bodies (2001) (39)
Dementia with lewy bodies--diagnosis and treatment. (2003) (39)
Effect Size Analyses of Souvenaid in Patients with Alzheimer’s Disease (2016) (38)
Reduced gastrointestinal absorption of calcium in dementia. (1990) (38)
Association studies between risk for late‐onset Alzheimer's disease and variants in insulin degrading enzyme (2005) (38)
Disturbances of consciousness in dementia with Lewy bodies associated with alteration in nicotinic receptor binding in the temporal cortex (2002) (38)
Foresight Mental Capital and Wellbeing Project: Mental Capital Through Life: Future Challenges (2014) (38)
Attenuation of Aβ deposition in the entorhinal cortex of normal elderly individuals associated with tobacco smoking (2005) (37)
Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer's disease: a cohort study (2012) (37)
Reaching the population with dementia drugs: what are the challenges? (2007) (36)
The CCTTT polymorphism in the NOS2A gene is associated with dementia with Lewy bodies (2000) (36)
Longitudinal study of cerebral blood flow SPECT in Parkinson's disease with dementia, and dementia with Lewy bodies (2005) (35)
Cholinergic and perfusion brain networks in Parkinson disease dementia (2016) (35)
Alpha4beta2 nicotinic receptor status in Alzheimer's disease using 123I-5IA-85380 single-photon-emission computed tomography. (2007) (35)
Apolipoprotein E and alpha‐1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies Distinctions between diseases (1998) (35)
Impact of less common and "disregarded" neurodegenerative pathologies on dementia burden in a population-based cohort. (2012) (34)
Alzheimer and vascular neuropathological changes associated with different cognitive States in a non-demented sample. (2012) (34)
Patterns and stages of α-synucleinopathy (2008) (34)
Lewy body dementia--clinical, pathological and neurochemical interconnections. (1997) (34)
Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias. (1999) (34)
Bilateral nucleus basalis of Meynert deep brain stimulation for dementia with Lewy bodies: A randomised clinical trial (2020) (34)
Driving, dementia and the Driver and Vehicle Licensing Agency: a survey of old age psychiatrists (2006) (33)
Development of assessment toolkits for improving the diagnosis of the Lewy body dementias: feasibility study within the DIAMOND Lewy study (2016) (33)
Does visuospatial memory in senile dementia of the Alzheimer type depend on the severity of the disorder? (1992) (32)
Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies (2006) (32)
Non-pharmacological interventions for Lewy body dementia: a systematic review (2017) (32)
The assessment of cognition in visually impaired older adults. (2013) (32)
Support and information needs following a diagnosis of dementia with Lewy bodies (2015) (31)
Commentary: DLB and PDD: the same or different? Is there a debate? (2009) (31)
Revisiting DLB Diagnosis: A Consideration of Prodromal DLB and of the Diagnostic Overlap With Alzheimer Disease (2018) (30)
Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel (2021) (30)
Do differences in visuospatial ability between senile dementias of the Alzheimer and Lewy body types reflect differences solely in mnemonic function? (1995) (30)
A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers (2018) (30)
Quantification and characterization of fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease. (2000) (29)
Diagnostic accuracy of 123 IFP-CIT SPECT in possible dementia with Lewy bodies (2008) (29)
Muscarinic acetylcholine receptor status in Alzheimer’s disease assessed using (R, R) 123I-QNB SPECT (2007) (28)
Neocortical concentrations of neuropeptides in senile dementia of the alzheimer and lewy body type: Comparison with parkinson's disease and severity correlations (1991) (28)
The Impact of Metrifonate Therapy on Caregivers of Patients with Alzheimer's Disease: Results from the MALT Clinical Trial (2000) (28)
Neuronal Loss and Α-Synuclein Pathology in the Superior Colliculus and Its Relationship to Visual Hallucinations in Dementia with Lewy Bodies. (2017) (28)
Dementia with Lewy bodies (1999) (28)
Nicotinic 123I-5IA-85380 single photon emission computed tomography as a predictor of cognitive progression in Alzheimer's disease and dementia with Lewy bodies. (2010) (27)
The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target (2018) (27)
Longitudinal change in 99mTcHMPAO cerebral perfusion SPECT in Parkinson’s disease over one year (2005) (27)
Symptoms associated with Lewy body disease in mild cognitive impairment (2017) (27)
Profiling conversation in Parkinson's disease with cognitive impairment (1999) (27)
Covariant perfusion patterns provide clues to the origin of cognitive fluctuations and attentional dysfunction in Dementia with Lewy bodies (2013) (26)
Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia. (2007) (26)
Extending the clinical research network approach to all of healthcare. (2011) (26)
A Prospective Study of Dementia with Lewy Bodies — Clinical Data (1998) (25)
Revision of assessment toolkits for improving the diagnosis of Lewy body dementia: The DIAMOND Lewy study (2018) (25)
Specific patterns of neuronal loss in the pulvinar nucleus in dementia with lewy bodies (2017) (25)
Of MCI and dementia: Improving diagnosis and treatment (2001) (25)
Cerebral ABC transporter-common mechanisms may modulate neurodegenerative diseases and depression in elderly subjects. (2014) (25)
A psychophysiological investigation of fluctuating consciousness in neurodegenerative dementias (1999) (25)
For Debate: Should novel antipsychotics ever be used to treat the behavioral and psychological symptoms of dementia (BPSD)? (2005) (24)
Good days and bad days: The lived experience and perceived impact of treatment with cholinesterase inhibitors for Alzheimer’s disease in the United Kingdom (2010) (24)
Plasma homocysteine and cognitive decline in older hypertensive subjects (2011) (24)
The K Variant of the Butyrylcholinesterase Gene Is Associated with Reduced Phosphorylation of Tau in Dementia Patients (2005) (24)
What explains variations in the clinical use of mild cognitive impairment (MCI) as a diagnostic category? (2008) (24)
Regional levels of physiological α-synuclein are directly associated with Lewy body pathology (2017) (23)
Extravascular fibrinogen in the white matter of Alzheimer’s disease and normal aged brains: implications for fibrinogen as a biomarker for Alzheimer’s disease (2019) (23)
Diagnosis and management of dementia with Lewy bodies : Third report of the DLB Consortium. Author's reply (2006) (23)
α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity (2022) (22)
Dementia with Lewy Bodies: Noncognitive symptoms in Lewy body dementia (1996) (22)
Changes to the lateral geniculate nucleus in Alzheimer's disease but not dementia with Lewy bodies (2015) (22)
Individual-Reader Diagnostic Performance and Between-Reader Agreement in Assessment of Subjects with Parkinsonian Syndrome or Dementia Using 123I-Ioflupane Injection (DaTscan) Imaging (2014) (22)
Abnormalities of functional cortical source connectivity of resting-state electroencephalographic alpha rhythms are similar in patients with mild cognitive impairment due to Alzheimer's and Lewy body diseases (2019) (21)
Involvement of α6/α3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [125I]-α-conotoxin MII binding in the thalamus and striatum. (2004) (21)
CLONIDINE IN TOURETTE SYNDROME (1981) (21)
Consecutive sessions of transcranial direct current stimulation do not remediate visual hallucinations in Lewy body dementia: a randomised controlled trial (2019) (21)
Lipids, lysosomes and mitochondria: insights into Lewy body formation from rare monogenic disorders (2021) (21)
Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disorders (2021) (20)
Clinical diagnosis of Lewy body dementia (2020) (20)
Levodopa may affect cortical excitability in Parkinson's disease patients with cognitive deficits as revealed by reduced activity of cortical sources of resting state electroencephalographic rhythms (2019) (20)
Quantitative neuropathology: an update on automated methodologies and implications for large scale cohorts (2017) (19)
The challenges of COVID‐19 for people with dementia with Lewy bodies and family caregivers (2020) (19)
Alzheimer's Disease and Other Disorders Associated With Dementia (2008) (19)
Multivariate Spatial Covariance Analysis of 99MTc-Exametazime SPECT Images in Dementia with Lewy Bodies and Alzheimer'S Disease: Utility in Differential Diagnosis (2013) (19)
Neuropathological Profile of Mild Cognitive Impairment From a Population Perspective (2012) (19)
Senile dementia of lewy body type—a review of clinical and pathological features: Implications for treatment (1995) (19)
Covariance 99mTc-Exametazime SPECT Patterns in Alzheimer’s Disease and Dementia with Lewy Bodies: Utility in Differential Diagnosis (2010) (19)
Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline (2007) (19)
Abnormal cortical neural synchronization mechanisms in quiet wakefulness are related to motor deficits, cognitive symptoms, and visual hallucinations in Parkinson's disease patients: an electroencephalographic study (2020) (18)
APOE Genotype and Alzheimer´s Disease (2000) (18)
Molecular changes in the absence of severe pathology in the pulvinar in dementia with Lewy bodies (2018) (18)
What are the relations between Lewy body disease and AD? (1998) (18)
Visual Hallucinations in Eye Disease and Lewy Body Disease. (2016) (17)
Do experienced diagnosticians agree about the diagnosis of dementia from survey data? The effects of informants' reports and interviewers' vignettes (1998) (16)
Subject Index Vol. 11, 2000 (2000) (16)
Textbook of Geriatric Neuropsychiatry (2001) (16)
No association between an intronic polymorphism in the presenilin-1 gene and Alzheimer's disease (1997) (16)
Dementia with Lewy Bodies : and Parkinson's Disease Dementia (2005) (16)
Donepezil and cardiac syncope: case report (2004) (15)
Pathological Changes to the Subcortical Visual System and its Relationship to Visual Hallucinations in Dementia with Lewy Bodies (2019) (15)
Has the management of Alzheimer's disease changed over the past 100 years? (2006) (15)
Levodopa use and sleep in patients with dementia with Lewy bodies (2009) (14)
Cholinesterase inhibitor use does not significantly influence the ability of 123I-FP-CIT imaging to distinguish Alzheimer’s disease from dementia with Lewy bodies (2007) (14)
Dopamine D2 receptors in demented patients with severe neuroleptic sensitivity. (1994) (14)
A follow‐up study of elderly depressives and Alzheimer‐type dementia—relationship with DST status (1991) (14)
Cholinesterase inhibitors in advanced Dementia with Lewy bodies: increase or stop? (2006) (14)
APOE and ACE polymorphisms and dementia risk in the older population over prolonged follow-up: 10 years of incidence in the MRC CFA Study (2009) (13)
Old age psychiatry (2002) (13)
Dementia in Parkinson's disease: common and treatable (2004) (13)
Lewy body diseases (2002) (12)
Tautological tangles in neuropathologic criteria for dementias associated with Lewy bodies (1996) (12)
Dementia with Lewy bodies. (2007) (12)
Dementia with Lewy bodies (1997) (12)
Loss of Musashi1 in Lewy body dementia associated with cholinergic deficit (2007) (12)
Somatostatin content and receptors in the cerebral cortex of depressed and control subjects. (1988) (12)
Lewy bodies and Alzheimer's disease (1993) (12)
No association between a polymorphism in the presenilin 1 gene and dementia with Lewy bodies (1997) (11)
Psychiatric features in diffuse Lewy body disease (1998) (11)
Propofol and electroconvulsive therapy in a patient at risk from acute intermittent porphyria. (1998) (11)
Neurotransmitter Correlates of Neuropsychiatric Symptoms in Dementia with Lewy Bodies (2003) (10)
Cognitive Decline in Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease: A Prospective Cohort Study. (2020) (10)
Lewy Body Disease (1995) (10)
Clinical Diagnostic Criteria for Lewy Body Dementia (1992) (10)
Progressive brain atrophy on serial MRI in dementia with lewy bodies: A comparison with Alzheimer's disease and vascular dementia (2000) (10)
The Clinical Trial Protocol of the Metrifonate in ALzheimer’s Trial (MALT) (1998) (10)
Author response: Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium (2018) (9)
Regional covariance of muscarinic acetylcholine receptors in Alzheimer’s disease using (R, R) [123I]-QNB SPECT (2015) (9)
An outbreak of viral gastroenteritis in a psychiatric hospital. (1989) (9)
PARIETAL WHITE MATTER LESIONS IN ALZHEIMER’S DISEASE ARE ASSOCIATED WITH CORTICAL NEURODEGENERATIVE PATHOLOGY AND NOT WITH SMALL-VESSEL DISEASE (2017) (9)
Transcranial direct current stimulation in Parkinson's disease dementia: A randomised double-blind crossover trial (2017) (9)
Distinct cognitive phenotypes in Alzheimer's disease in older people (2013) (9)
Involvement of alpha6/alpha3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [(125)I]-alpha-conotoxin MII binding in the thalamus and striatum. (2004) (8)
Clinical Characteristics of Patients with Cognitive Impairment and Dementia Attending a Casualty Department with Falls (1997) (8)
Cholinesterase inhibitors and Alzheimer’s disease: Patient, carer and professional factors influencing the use of drugs for Alzheimer’s disease in the United Kingdom (2010) (8)
Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes (2021) (8)
Prospective predictors of decline v. stability in mild cognitive impairment with Lewy bodies or Alzheimer's disease (2020) (8)
Inflammation in dementia with Lewy bodies (2022) (8)
Clinical Diagnostic Criteria for Dementia with Lewy Bodies (2017) (8)
Lewy Body Dementia Association’s Research Centers of Excellence Program: Inaugural Meeting Proceedings (2019) (8)
Dementia with Lewy bodies and Parkinson's disease dementia - two synucleinopathies (2003) (8)
Thalamic D 2 receptors in dementia with Lewy bodies, Parkinson’s disease, and Parkinson’s disease dementia (2007) (8)
a2-Adrenoreceptor antagonism and serotonin reuptake inhibition in patients with Parkinson disease and depression (2000) (8)
Alexia in dementia of the Alzheimer's type (1993) (8)
Supporting clinical research in the NHS in England: the National Institute for Health Research Dementias and Neurodegenerative Diseases Research Network (2012) (7)
Patient and Informant Views on Visual Hallucinations in Parkinson Disease. (2015) (7)
Dementia with Lewy bodies and other difficult diagnoses (2004) (7)
HEADWAY-DLB: A MULTINATIONAL STUDY EVALUATING THE SAFETY AND EFFICACY OF INTEPIRDINE (RVT-101) IN DEMENTIA WITH LEWY BODIES (2017) (7)
Depressive symptoms are associated with daytime sleepiness and subjective sleep quality in dementia with Lewy bodies (2015) (7)
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into the complex genetic architecture (2020) (7)
Lewy bodies and neuronal loss in subcortical areas and disability in non-demented older people: a population based neuropathological cohort study (2009) (6)
Aggressive behaviour in dementia and its pharmacologic treatment: A review (1995) (6)
Clinical aspects of dementia with Lewy bodies. (2008) (6)
Progression to Dementia in Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease (2021) (6)
Psychotic symptoms in Alzheimer's disease (1992) (6)
Cholinergic muscarinic M1/M4 receptor networks in dementia with Lewy bodies (2020) (6)
[Drug treatment of emotional and cognitive dysfunction in dementia]. (1998) (6)
Understanding changes in cholinergic function: implications for treating dementia. (2002) (6)
Abnormalities of resting-state EEG in patients with prodromal and overt dementia with Lewy bodies: Relation to clinical symptoms (2020) (6)
Author response: Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB (2017) (6)
Muscarinic acetylcholine receptor status in Alzheimer's disease assessed using (2007) (5)
Elderly individuals with FTLD. (2013) (5)
Neuroanatomical and neurochemical changes in affective disorders in old age (1991) (5)
Diagnosis of Dementia With Lewy Bodies (2004) (5)
Dementia with Lewy bodies: A clinical overview (2017) (4)
TOP CITED PAPERS IN INTERNATIONAL PSYCHOGERIATRICS: 1. LONG-TERM USE OF RIVASTIGMINE IN PATIENTS WITH DEMENTIA WITH LEWY BODIES: AN OPEN-LABEL TRIAL (2009) (4)
Management of parkinsonism and psychotic depression in a case of acute intermittent porphyria. (1997) (4)
Advances in the diagnosis and treatment of dementia with Lewy bodies. Introduction. (2004) (4)
Predicting response to rivastigmine in dementia with Lewy Bodies (2002) (4)
Neuropsychiatric symptoms in the course of Wegener's granulomatosis. (1985) (4)
Introduction of a Management Toolkit for Lewy Body Dementia: A Pilot Cluster‐Randomized Trial (2020) (4)
Dementia with Lewy bodies: Impact of co‐pathologies and implications for clinical trial design (2022) (4)
Progression of Clinical Features in Lewy Body Dementia Can Be Detected Over 6 Months (2021) (4)
Savings from sub-groups?: Policy guidance and Alzheimer's disease treatments (2010) (4)
Galantamine for vascular dementia (2002) (4)
[abstract] Marked neuroleptic sensitivity in dementia with Lewy bodies and Parkinson's disease (2003) (4)
2880 dementia with lewy bodies (2000) (4)
[Cholinesterase inhibitors in Norway--effectiveness and side effects in clinical practice]. (2003) (4)
Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis (2020) (3)
Dementia with Lewy bodies. (2002) (3)
Dementia with Lewy Bodies: Management of the noncognitive symptoms of Lewy body dementia (1996) (3)
Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations (2022) (3)
O1-02-04 Dopamine transporter loss visualised with FP-CIT spect indementia with Lewy bodies (2004) (3)
A Physician’s Guide to Practical Management (2005) (3)
II.3 Dementia with Lewy bodies (2006) (3)
Pharmacological treatment of dementia with Lewy bodies (2006) (3)
Integrated Analysis of [123I]FP-CIT (DaTscan; Ioflupane I123 Injection) SPECT Brain Imaging - Diagnostic Effectiveness in Patients with Movement Disorders and/or Dementia (S8.004) (2014) (3)
Decreased immunoreactivities of neocortical AMPA receptor subunits correlate with motor disability in Lewy body dementias (2013) (3)
Clinical presentations in monozygotic twins with dementia with Lewy bodies. (2002) (3)
Discharge patterns from a psychogeriatric inpatient unit (1995) (3)
Social and Clinical Characteristics of Patients with Cognitive Impairment and Dementia Attending Casualty with Falls (1997) (3)
The effect of candesartan cilexetil on cognitive function in older adults with mild hypertension (2003) (3)
Common Variants Near ZIC1 and ZIC4 in Autopsy‐Confirmed Multiple System Atrophy (2022) (3)
Dopamine metabolism in postmortem caudate-nucleus in neurodegenerative disorders (1994) (3)
Accuracy of possible and probable Alzheimer Disease diagnosis: a methodological comparison using SPM and Principal Component Analysis (2004) (3)
Clinical Criteria for Dementia with Lewy Bodies (2002) (3)
Clinical Characteristics of Patients with Cognitive Impairment and Dementia Attending an Accident and Emergency Department with Falls (1998) (2)
Introduction of an assessment toolkit associated with increased rate of DLB diagnosis (2021) (2)
Delirium and dementia (2004) (2)
The Nicotinic Cholinergic System and ß-Amyloidosis (1997) (2)
Who will be eligible? An investigation of the dementia population eligible for cholinesterase treatment following the change in NICE guidance (2009) (2)
The effects of donepezil on nicotinic receptor status in dementia: a 123I-5IA-85380 SPECT study (2007) (2)
Attention and fluctuating attention in dementia with Lewy bodies and Alzheimer's disease (2001) (2)
Behavioral and Psychological Symptoms of Dementia and Dementia With Lewy Bodies (2000) (2)
Early Bottom-Up Visual Information Processing in Hallucinating Patients with Parkinson’s Disease with Dementia: A Preliminary Visual Evoked Potential Study (2015) (2)
Prevalence and severity of symptoms suggestive of gastroparesis in prodromal dementia with Lewy bodies (2019) (2)
Clinical Diagnosis of Dementia With Lewy Bodies (2005) (2)
Dementia with Lewy Bodies: Introduction (1996) (2)
Diagnostic performance of ioflupane I123 injection (DaTSCAN™ Normal 0 false false false EN-GB X-NONE X-NONE ) in patients with movement disorders and dementia (2014) (2)
Still PADing along: Perception and attention remain key factors in understanding complex visual hallucinations (2005) (2)
Clinical trials of treatment for noncognitive symptoms of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. (1997) (2)
How dementia and neurodegenerative disease clinical research networks have enhanced research delivery in England (2014) (2)
[Dementia with Lewy bodies]. (2002) (2)
[Alzheimer's disease and genetics]. (2013) (2)
KEY PAPERS IN GERIATRIC PSYCHIATRY. SERIES EDITOR: ALISTAIR BURNS Correlation of Cholinergic Abnormalities with Senile Plaques and Mental Test Scores in Senile Dementia. E. Perry, B. Tomlinson, G. Blessed, K. Bergmann, P. Gibson and R. Perry,British Medical Journal (1978)2, 1457–59. (1996) (2)
[Psychosis in Parkinson's disease]. (2012) (2)
Efficacy and safety of sabeluzole in patients with probable Alzheimer's disease (1994) (2)
[Electroconvulsive treatment in parkinsonism]. (1993) (1)
The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis (2014) (1)
THE HUMAN BRAINOME: HUMAN BRAIN GENOME, TRANSCRIPTOME, AND PROTEOME INTEGRATION (2016) (1)
Alzheimer's Disease, by Paul Dash and Nicole Villemarette-Pittman (2005) (1)
Supporting clinical research in the NHS in England: the National Institute for Health Research Dementias and Neurodegenerative Diseases Research Network (2012) (1)
Adjunct treatment with levodopa in a patient with dementia with Lewy bodies, delusions and severe neuroleptic hypersensitivity syndrome: some comments (2010) (1)
DIAGNOSIS AND TREATMENT OF PSYCHOSIS IN DEMENTIA WITH LEWY BODIES (1999) (1)
Chapter 9 Dementia with Lewy Bodies and Parkinson's Disease Dementia (2007) (1)
Levodopa acutely improves alertness in Parkinsonism (2005) (1)
3. Striatal uptake of 123I-FPCIT in dementia with Lewy bodies, Alzheimerʼs disease and Parkinsonʼs disease (2003) (1)
Tobacco use is associated with attenuation of beta-amyloidosis in hippocampus and entorhinal cortex of normal elderly individuals (2002) (1)
Cognitive Performance in a UK Cohort of 85 Year Olds: The Newcastle 85+ Study (2011) (1)
What's new in… Psychiatry: dementia with Lewy bodies (2004) (1)
Regulatory Issues Concerning Behavioral and Psychological Symptoms of Dementia in Europe (2000) (1)
Global phase 2b efficacy and safety trial of florbetaben for beta-amyloid brain positron emission tomography in Alzheimer's disease (2011) (1)
Subject Index Vol. 14, 2002 (2002) (1)
VALIDATION BY NEUROPATHOLOGY OF FP-CIT NEUROIMAGING IN DEMENTIA WITH LEWY BODIES (2017) (1)
Can multi-disciplinary intervention prevent falls in patients with cognitive impairment and dementia attending a casualty department? (2000) (1)
Postmortem Investigation of Serotonergic and Peptidergic Hypotheses of Affective Illness (1989) (1)
Recommendations for the diagnosis and treatment of Alzheimer's disease and other disorders associated with dementia: The EFNS guidelines (2008) (1)
The effect of candesartan on cognitive function in older adults with mild hypertension (2003) (1)
Post-mortem investigation of neurochemical and neuro-peptidergic hypothesis of depression (1988) (1)
Dementia with Lewy bodies. (2002) (1)
Impairments in attention and fluctuating attention distinguish between dementia with lewy bodies and Alzheimer's disease (2000) (1)
Improved attentional performance in DLB and PDD following donepezil treatment (2004) (1)
Dementia with Lewy Bodies: Résumé of treatment workshop sessions (1996) (1)
Decline in cognitive function in Parkinson's disease may be due to dementia with Lewy bodies (1998) (1)
Contents Vol. 3, 1992 (1992) (1)
[Emotional and cognitive disorders in Parkinson disease]. (1998) (1)
Dementia with Lewy Bodies: Biographical note on F. H. Lewy (1996) (1)
Dementia with Lewy bodies: a clinical and historical overview (2010) (1)
Classification of Patients with Alzheimer's Disease and Dementia with Lewy Bodies using Resting EEG Selected Features at Sensor and Source Levels: A proof-of-concept study. (2021) (1)
Cholinergic pathology in Lewy body dementia (2006) (1)
Clinical prevalence of Lewy body dementia (2018) (1)
Visual-perception in Parkinson's disease with dementia (2003) (1)
Serial MR image registration and analysis techniques applied to studies of differential cerebral atrophy in late-onset dementia. (2000) (1)
Different abnormalities of electroencephalographic (EEG) markers in quiet wakefulness are related to visual hallucinations in patients with Parkinson’s and Lewy body diseases (2020) (1)
Improving the diagnosis and management of Lewy body dementia: the DIAMOND-Lewy research programme including pilot cluster RCT (2021) (1)
205 Psychological function in dementia with lewy bodies and senile dementia of Alzheimer's type (1996) (1)
RENEWAL: REpurposing study to find NEW compounds with Activity for Lewy body dementia—an international Delphi consensus (2022) (1)
[Dementia and Parkinson disease]. (2007) (1)
Advances in the Diagnosis and Treatment of Dementia with Lewy Bodies (2003) (1)
Management of Parkinson’s disease dementia and dementia with Lewy bodies (2010) (1)
P.3.008 Dopaminergic and nicotinic interactions in the human striatum in dementia with lewy bodies, chronic schizophrenia and Parkinson's disease (1996) (1)
Can parkinsonian phenotype be used to predict levodopa response in extrapyramidal syndromes with and without dementia (2004) (0)
Contents Vol. 16, 2003 (2003) (0)
Contents Vol. 11, 2000 (2000) (0)
[Should Alzheimer disease be treated with tacrine? Review of the literature]. (1996) (0)
Determination of the alpha-1 anti-chymotrypsin polymorphism in Alzheimer's disease (1996) (0)
Different abnormalities of electroencephalographic (EEG) markers in quiet wakefulness are related to motor visual hallucinations in patients with Parkinson’s and Lewy body diseases (2020) (0)
2013 I PA J unior R esearch A wards - F irst P rize W inner Covariant perfusion patterns provide clues to the origin of cognitive fluctuations and attentional dysfunction in Dementia with Lewy bodies (2013) (0)
Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations (2016) (0)
[Violent behavior of patients--is it predictable?]. (1992) (0)
Diagnostic issues in dementia: Advancing the research agenda for DSM‐V, APA: Sunderland, 2007. (2009) (0)
P1-273: Predictive diagnostic accuracy of 123I-FP-CIT spect in possible dementia with Lewy bodies: A 12-month follow-up study (2008) (0)
[abstract] Diagnosis and treatment of dementia with Lewy Bodies: State of the art (2002) (0)
Baborie et al - Elderly Individuals with FTLD - Arch Neurol.2011.3323v1 (2015) (0)
International Journal of Geriatric Psychiatry the Characterisation and Impact Of`¯uctuating' Cognition in Dementia with Lewy Bodies and Alzheimer's Disease (0)
Dementia with Lewy Bodies: Index (1996) (0)
Cortical Lewy body disease: dementia with Lewy bodies and Parkinson's disease with dementia (2008) (0)
Clinical, pathological and neurochemical characteristics of Lewy body dementia (1995) (0)
The pharmacological management of psychotic behaviour in the elderly (2000) (0)
Lewy Body Dementia Association’s Research Centers of Excellence Program: Inaugural Meeting Proceedings (2019) (0)
Journal Pre-proof Bilateral Nucleus Basalis of Meynert Deep Brain Stimulation for dementia with Lewy bodies A Randomised Clinical Trial A (2020) (0)
Fluctuating Cognition Rating Scale (2021) (0)
Analysis of Primary Visual Cortex in Dementia with Lewy Bodies Indicates Abnormal Inhibitory Neurotransmission and Involvement of Bottom Up Pathways (2018) (0)
Consecutive sessions of transcranial direct current stimulation do not remediate visual hallucinations in Lewy body dementia: a randomised controlled trial (2019) (0)
Hallucinations in patients with parkinsonism: Clinical features and management (2002) (0)
P2-147 123I-QNB spect demonstrates loss of cholinergic muscarinic receptors in Alzheimer's disease, but occipital increases in dementia with Lewy bodies and Parkinson's disease dementia (2004) (0)
What can we learn about the concept and underlying biology of intermediate cognition from the longstanding population based cohort CFAS (2011) (0)
The SNCA locus in dementia with Lewy bodies (2010) (0)
Predictors of further falls in patients with cognitive impairment and dementia attending an accident and emergency facility (2000) (0)
Current Perspectives in the Diagnosis and Treatment of Alzheimer's Disease: Satellite Symposium to the 5th International Symposium on Advances in Alzheimer's Disease Therapy (INSAAT), Geneva, April 1998 (1998) (0)
P2-234 Alzheimer's disease and dementia with Lewy bodies show different regional patterns of evolving atrophy using fluid registration of serial MRI scans (2004) (0)
The role of FP-CIT in the differential diagnosis of Alzheimerʼs and Lewy body dementia (2001) (0)
Alzheimer's disease and related disorders: Etiology, pathogenesis and therapeutics. Review (2000) (0)
PRELIMINARY VALIDATION OF THE NORTH-EAST VISUAL HALLUCINATION SCALE SEVERITY SCORE IN LEWY BODY DISEASES (2018) (0)
ABNORMALITIES OF ELECTROENCEPHALOGRAPHIC (EEG) MARKERS IN QUIET WAKEFULNESS ARE RELATED TO MOTOR DEFICITS, COGNITIVE SYMPTOMS, AND VISUAL HALLUCINATIONS IN PARKINSON’S DISEASE PATIENTS (2019) (0)
Classification and diagnostic criteria for dementia with Lewy bodies (2006) (0)
IC-P-059 Measurement of the α4β2 nicotinic receptor in vivo in Alzheimer’s disease with 123I-5IA-85380 SPECT (2006) (0)
Correction: Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations (2022) (0)
Brain Ageing and Dementia in Newcastle: past, present and future An event to mark the contributions of Professors Robert and Elaine Perry (2010) (0)
Comparison of clinical, FP-CIT spet imaging, and autopsy diagnosis of DLB (2006) (0)
013 Progression of clinical features in Lewy body dementia can be detected over six months (2021) (0)
Tc-99m HMPAO SPECT image analysis in dementia with Lewy bodies and Alzheimer's disease using statistical paramentric mapping (2002) (0)
Contents Vol. 19, 2005 (2005) (0)
Dementia with Lewy Bodies: Plate section (1996) (0)
Poor Reactivity of Posterior Electroencephalographic Alpha Rhythms During the Eyes Open Condition in Patients with Dementia Due to Parkinson’s Disease (2022) (0)
Neuroendocrine abnormalities in depression and the influence of drugs (1989) (0)
The Lewy Body Dementia Spectrum (Alpha Synucleinopathies) (2010) (0)
Dementia with Lewy Bodies: Guidelines for the selection of cortical areas for the evaluation of Lewy body distribution and proposed diagnostic rating protocol (1996) (0)
Transcranial direct current stimulation in Parkinson ’ s disease dementia : a randomised crossover trial (2017) (0)
Pathological Changes to the Subcortical Visual System and its Relationship to Visual Hallucinations in Dementia with Lewy Bodies (2019) (0)
BJP volume 172 issue 4 Cover and Front matter (1998) (0)
Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia (2018) (0)
[Antipsychotic agents--not to patients with dementia?]. (1999) (0)
COVID-19: Challenges for people with Dementia with Lewy Bodies (2020) (0)
Donepezil treatment and withdrawal in patients with dementia with lewy bodies (DLB) and patients with Parkinsons disease plus DLB (2002) (0)
New advances in Lewy body disease (2021) (0)
IC-102-01 The use of DaTSCAN spect to facilitate the differential diagnosis of dementia with lewy bodies (2006) (0)
AG.04 Parkinson's disease and Lewy body disease: the same or different? (2011) (0)
Early diagnosis for Lewy Body Disease and treatment (2012) (0)
Unexplained Delirium, Atypical Dementia, and Prodromal DLB (2016) (0)
THE EVALUATION OF MTOR PATHWAY DYSREGULATION AS A NOVEL BLOOD-BASED PHENOTYPIC RISK BIOMARKER FOR THE ASSESSMENT OF ALZHEIMER'S DISEASE AND DEMENTIA (2014) (0)
Psychiatric Tutor—Rumour or Reality? (1984) (0)
Prodromal features of DLB/PDD (2013) (0)
Subject Index Vol. 19, 2005 (2005) (0)
Visual hallucinations in neurological disease: pathophysiology and management (2020) (0)
From James Parkinson to Friederich Lewy: leaving landmarks for further research journeys. (2003) (0)
Neurobiology of behavioral disturbances in dementia: Implications for clinical practice [abstract] (2002) (0)
Introduction (1998) (0)
Dementia with Lewy Bodies and Parkinson’s Disease Dementia Show No differences in Resting State Functional MRI (2015) (0)
A comparison of the use of carers' diaries and a computerised test battery to measure the fluctuations in patients with lewy bodies (DLB) (2003) (0)
RESEARCH INFRASTRUCTURE SERVICE DEVELOPMENTS TO SUPPORT INCREASED DEMENTIA RESEARCH IN THE U.K. (2017) (0)
Altered tau processing: its role in development of dementia in Alzheimer's disease and Lewy body disease (1996) (0)
The Differential Diagnosis of Dementia (1994) (0)
DIAGNOSIS OF DEMENTIA IN PARKINSON’S DISEASE IN CLINICAL PRACTICE (2017) (0)
Loss of synaptic proteins and choline acetyltransferase in primary and secondary visual cortex in dementia with Lewy bodies (2008) (0)
Drs. Ballard and McKeith Reply (2000) (0)
Reports from Trainees' Meetings (1983) (0)
An economic approach to the measurement of benefits of cholinesterase inhibitors in Alzheimer's disease (2003) (0)
DEMENTIA WITH LEWY BODIES (DLB): NEW DIAGNOSTIC CONCEPTS (2017) (0)
Dementia with Lewy Bodies: Foreword (1996) (0)
Impairments to the lateral geniculate nucleus in Alzheimer ’ s disease but not dementia with Lewy bodies (2018) (0)
Alzheimer's Disease: New Horizons (2014) (0)
Diagnostic performance of ioflupane I123 injection (DaTSCAN) in patients with movement disorders and dementia (2014) (0)
[123I]FP-CIT (DaTscan; Ioflupane I123 Injection) SPECT brain imaging - Diagnostic effectiveness in patients with movement disorders and/or dementia (2014) (0)
Future trends in cholinergic therapy (2003) (0)
I-123-QNB SPECT demonstrates loss of cholinergic muscarinic receptors in Alzheimer's disease, but occipital increases in dementia with lewy bodies and Parkinson's disease dementia (2004) (0)
[abstract] Muscarinic acetylcholine receptor status in Alzheimer's disease assessed using (R, R) [I-123]-QNB SPECT (2006) (0)
Grey matter atrophy in prodromal stage of dementia with Lewy bodies and Alzheimer’s disease (2016) (0)
Donald Eccleston (2018) (0)
Longer term health and social outcomes in patients with cognitive impairment and dementia who attend the casualty department with a fall (2000) (0)
“WHAT DIFFERENCE DOES IT MAKE?” CLINICIAN VIEWS ON DIAGNOSING LEWY BODY DEMENTIA (2017) (0)
IC-P1-041: Predictive diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies: A 12-month follow-up study (2008) (0)
North-East Visual Hallucinatory Inventory (2019) (0)
Introduction (2003) (0)
Dementia with Lewy Bodies: Group photograph (1996) (0)
Electrophysiological Correlates of Attentional Dysfunction in Dementia with Lewy Bodies (2015) (0)
640 Consensus criteria for the clinical diagnosis of dementia with Lewy bodies (DLB) (1996) (0)
Correction: Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations (2022) (0)
Clinical symptoms in mild cognitive impairment with Lewy bodies: Frequency, time of onset, and discriminant ability (2023) (0)
Dementia with Lewy Bodies: Consensus criteria for the clinical diagnosis of dementia with Lewy bodies (DLB) (1996) (0)
P3-416 PROFILE OF INTRACELLULAR CHOLESTEROLTRAFFICKING IN POSTMORTEM BRAINS OF DOWN SYNDROME AND ALZHEIMER DISEASE (2017) (0)
S1-04-04 Dementia with Lewy bodies (2006) (0)
Subject Index Vol. 16, 2003 (2003) (0)
91 DEMENTIA WITH LEWY BODIES (2002) (0)
Commentary (2005) (0)
Dementia with Lewy bodies: an update and outlook (2019) (0)
P2-322 Measurement of the α4β2 nicotinic receptor in vivo in Alzheimer’s disease with 123I-5ia-85380 SPECT (2006) (0)
Increased salivary cortisol in late- but not early-onset depression: Relationship with hippocampal volume (2002) (0)
Genome-wide association study of autopsy-confirmed Multiple System Atrophy identifies common variants near ZIC1 and ZIC4 (2021) (0)
THE FUTURE OF DLB: NEW CRITERIA AND NEW TRIALS? (2014) (0)
Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias (2023) (0)
Fluctuations in attention: PD dementia vs DLB with parkinsonism (2002) (0)
Heart rate variability is reduced in dementia with Lewy bodies but not Alzheimer’s disease or vascular dementia. (2003) (0)
Subject Index Vol 3, 1992 (1992) (0)
Effects of Propranolol on Aggressive Behaviour in Elderly Patients with Dementia (1994) (0)
[meeting abstract] Decreased levels of amyloid-beta peptide in the entorhinal cortex of normal elderly individuals associated with tobacco smoking (2005) (0)
Cholinergic and Monoaminergic Correlates of Clinical Symptoms in Dementia with Lewy Bodies (2002) (0)
THE LEWY BODY DEMENTIA ASSOCIATION RESEARCH CENTERS OF EXCELLENCE PROGRAM: TOWARD OPTIMIZING CLINICAL CARE AND CLINICAL TRIAL INFRASTRUCTURE (2018) (0)
GEOGRAPHICAL VARIATIONS IN DIAGNOSTIC RATES FOR DEMENTIA WITH LEWY BODIES IN CLINICAL SERVICES (2017) (0)
Decreased levels of amyloid beta peptide in the brains of smokers (2005) (0)
The spectrum of dementia with Lewy bodies (DLB)–prodromal to end-stage (2014) (0)
DEMENTIAS PORTFOLIO DEVELOPMENT ACTIVITIES: UNITING AND SUPPORTING THE RESEARCH COMMUNITY TO INCREASE RESEARCH INCOME (2017) (0)
Cerebral atrophy in dementia with Lewy bodies studied using voxel-based morphometry (2002) (0)
Management of Noncognitive Symptoms in Dementia with Lewy Bodies (1998) (0)
TISSUE MICROARRAY AND QUANTITATIVE NEUROPATHOLOGY: A HIGH THROUGHPUT METHODOLOGY FOR NEUROPATHOLOGICAL ASSESSMENT OF LARGE SCALE COHORTS (2017) (0)
FP-CIP SPET: Distinction of dementia with Lewy Bodies from Alzheimer's disease (2002) (0)
Clinical characteristics of patients with cognitive impairment and dementia attending an accident and emergency facility with falls (1998) (0)
P2-236 A voxel-based study of Parkinson's disease with and without dementia (2004) (0)
50 Early diagnosis for Lewy body disease and treatment (2012) (0)
Saccadic eye movements in dementia with Lewy bodies and Parkinson's disease dementia (2006) (0)
Donald Eccleston, FRCPsych, PhD, DSc (2018) (0)
The utility of attention measurement in evaluating therapeutic responses, in cholinergic dementias [abstract] (2002) (0)
Comparison of clinical, fp-cit spet imaging and neuropathological diagnosis of DLB at autopsy (2007) (0)
Results of a multi-centre study of DaTSCAN in dementia with Lewy bodies (2007) (0)
Clinical characteristics of fallers with cognitive impairment and dementia who comply with multi-disciplinary post-fall intervention (2000) (0)
Hypertension as a treatment target for prevention of dementia: Effects of candesartan on cognitive decline in older hypertensives in the SCOPE substudy, and comparison to normotensive controls (2009) (0)
Dementia with Lewy Bodies: Clinical Management (2001) (0)
Contents Vol. 14, 2002 (2002) (0)
Assessment Toolkits for Lewy Body Dementia (2020) (0)
What you always wanted to know about… Lewy Bodies (2007) (0)
Reactivity of posterior cortical electroencephalographic alpha rhythms during eyes opening in cognitively intact older adults and patients with dementia due to Alzheimer's and Lewy body diseases (2022) (0)

This paper list is powered by the following services:

Other Resources About Ian G. McKeith

en.wikipedia.org

What Schools Are Affiliated With Ian G. McKeith?

Ian G. McKeith is affiliated with the following schools:

Newcastle University